Exane Derivatives’s Vanguard Total Bond Market BND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,937
Closed -$154K 816
2022
Q1
$154K Buy
+1,937
New +$158K 0.04% 394
2021
Q4
Sell
-1,937
Closed -$166K 889
2021
Q3
$166K Hold
1,937
0.04% 433
2021
Q2
$166K Buy
+1,937
New +$165K 0.04% 444

Other funds holding BND

Exane Derivatives's BND Position: Q2 2022 in Review

Exane Derivatives sold out of Vanguard Total Bond Market (BND) in Q2 2022, closing a stake of 1,937 shares — an estimated $154K sold.

Exane Derivatives first reported a position in BND in Q2 2021 and held it in 3 quarters. The position peaked at $166K in Q2 2021. 1,189 funds tracked by Wall St. Rank hold BND as of Q2 2022.

  • Exane Derivatives reported no remaining Vanguard Total Bond Market position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,937 Vanguard Total Bond Market shares in Q2 2022, an estimated $154K.
  • Exane Derivatives first reported a position in Vanguard Total Bond Market in Q2 2021 and held it in 3 quarters.
  • Exane Derivatives's Vanguard Total Bond Market position peaked at $166K in Q2 2021.
  • 1,189 funds tracked by Wall St. Rank held Vanguard Total Bond Market as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.